NCT06638489

Brief Summary

This study aimed to evaluate the impact of High-Intensity Focused Electromagnetic Therapy (HIFEM) combined with Pelvic Floor Muscle Training (PFMT) versus PFMT alone on urine leakage and quality of life in primiparous and multiparous women with stress urinary incontinence. Women aged 30 years or older exhibiting symptoms of stress urinary incontinence were randomized into two treatment groups. The experimental group received both HIFEM and PFMT, while the control group received only PFMT. The treatment continued for 6 weeks. Evaluations measured at baseline and post-intervention included the 1-hour Pad Test, the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI-SF), and sonography to assess bladder neck movement.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 15, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2024

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

October 9, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 15, 2024

Completed
Last Updated

October 15, 2024

Status Verified

October 1, 2024

Enrollment Period

11 months

First QC Date

October 9, 2024

Last Update Submit

October 11, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • 1-hour pad test

    It measures the total amount of urine leakage by weighing the pad after performing several standardized activities over the course of an hour.

    Baseline and the end of the 6-week intervention

Secondary Outcomes (2)

  • International Consultation on Urinary Incontinence questionnaire (ICIQ-UI-SF)

    Baseline and the end of the 6-week intervention

  • Bladder neck movement

    Baseline and the end of the 6-week intervention

Study Arms (2)

experimental group

EXPERIMENTAL

The experimental group received both High-Intensity-Focused-Electromagnetic-Therapy (HIFEM) combined with Pelvic-Floor-Muscle-Training (PFMT)

Other: High-Intensity-Focused-Electromagnetic-Therapy (HIFEM)Other: Pelvic-Floor-Muscle-Training (PFMT)

control group

EXPERIMENTAL

the control group received only Pelvic-Floor-Muscle-Training (PFMT)

Other: Pelvic-Floor-Muscle-Training (PFMT)

Interventions

The HIFEM stimulation was administered using an Emsella instrument (manufactured by BTL Industry Inc., Boston, MA). The frequency ranged between 50 and 60Hz, and the intensity was as high as the patient could tolerate, which was usually up to 100%.

experimental group

The PFMT protocol was that outlined by previous study. The participants were instructed to execute 5 rapid contractions over a span of 3 seconds and 10 prolonged contractions, each lasting between 3 to 8 seconds, with intervals of 10 seconds for relaxation in between, all while in a crook-lying position.

control groupexperimental group

Eligibility Criteria

Age30 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Primipara or Multipara women aged 30 years or older with symptoms of stress urinary incontinence;

You may not qualify if:

  • Those who had any contraindication for High-Intensity-Focused-Electromagnetic-Therapy (HIFEM);
  • prior surgery for incontinence;
  • taking drugs for bladder dysfunction or diuretics;
  • hormone therapy;
  • urgent or mixed urinary incontinence;
  • incontinence associated with a neurologic condition;
  • inability to perform voluntary pelvic floor muscle contractions;
  • cognitive impairment or dementia, major neurological disorders (such as stroke, cerebral palsy, multiple sclerosis);
  • inability to carry out the treatment or evaluation;
  • uncontrolled hypertension.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hong Kong Metropolitan University

Hong Kong, Hong Kong, 999077, China

Location

Related Publications (1)

  • Chan WS, Chow WT, Poon YT, Tsang CSL, Yuen HHL, Lui EWY, Wong YT, Tsang WWN. Effects of High-Intensity Focused Electromagnetic Therapy (HIFEM) With Pelvic Floor Muscle Training in Mothers Living With Incontinence: A Pilot for a Randomized Controlled Trial. Womens Health Issues. 2026 Jan 24:S1049-3867(25)00160-4. doi: 10.1016/j.whi.2025.12.002. Online ahead of print.

MeSH Terms

Conditions

Urinary Incontinence, Stress

Condition Hierarchy (Ancestors)

Urinary IncontinenceUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 9, 2024

First Posted

October 15, 2024

Study Start

June 15, 2023

Primary Completion

May 1, 2024

Study Completion

May 15, 2024

Last Updated

October 15, 2024

Record last verified: 2024-10

Locations